J. Cao

760 total citations
22 papers, 574 citations indexed

About

J. Cao is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, J. Cao has authored 22 papers receiving a total of 574 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Ophthalmology, 8 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Molecular Biology. Recurrent topics in J. Cao's work include Retinal Diseases and Treatments (5 papers), Corneal Surgery and Treatments (4 papers) and Glaucoma and retinal disorders (4 papers). J. Cao is often cited by papers focused on Retinal Diseases and Treatments (5 papers), Corneal Surgery and Treatments (4 papers) and Glaucoma and retinal disorders (4 papers). J. Cao collaborates with scholars based in United States, China and Canada. J. Cao's co-authors include D. Scott McLeod, Gerard A. Lutty, L. M. Hjelmeland, C. Merges, Chuanhai Cao, Janice Kim, R L Nagel, Peter Vanderslice, Bradley W. McIntyre and Makoto Taomoto and has published in prestigious journals such as NeuroImage, Investigative Ophthalmology & Visual Science and British Journal of Ophthalmology.

In The Last Decade

J. Cao

19 papers receiving 559 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Cao United States 7 429 350 90 52 42 22 574
Masahiko Yokoi Japan 14 374 0.9× 248 0.7× 69 0.8× 10 0.2× 18 0.4× 26 504
Hasanain Shikari United States 11 439 1.0× 662 1.9× 43 0.5× 16 0.3× 116 2.8× 15 817
Mostafa Hanout United States 14 581 1.4× 269 0.8× 130 1.4× 9 0.2× 21 0.5× 34 706
Kenneth T. Eng Canada 14 656 1.5× 406 1.2× 92 1.0× 15 0.3× 13 0.3× 30 734
Kishiko Ohkoshi Japan 15 522 1.2× 275 0.8× 175 1.9× 20 0.4× 54 1.3× 35 732
William Ayliffe United Kingdom 9 286 0.7× 182 0.5× 74 0.8× 9 0.2× 38 0.9× 15 463
Andrés F. Lasave United States 17 534 1.2× 262 0.7× 65 0.7× 29 0.6× 6 0.1× 31 635
Hatice Tuba Atalay Türkiye 14 425 1.0× 185 0.5× 106 1.2× 10 0.2× 9 0.2× 50 552
Alfonso Giovannini Italy 17 707 1.6× 335 1.0× 109 1.2× 5 0.1× 22 0.5× 44 823
M. Asencio Durán Spain 10 189 0.4× 67 0.2× 46 0.5× 18 0.3× 25 0.6× 34 272

Countries citing papers authored by J. Cao

Since Specialization
Citations

This map shows the geographic impact of J. Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Cao more than expected).

Fields of papers citing papers by J. Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Cao. The network helps show where J. Cao may publish in the future.

Co-authorship network of co-authors of J. Cao

This figure shows the co-authorship network connecting the top 25 collaborators of J. Cao. A scholar is included among the top collaborators of J. Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Cao. J. Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wykoff, Charles C., J. Cao, Yara Lechanteur, et al.. (2025). Effect of Pegcetacoplan on Aqueous Humor Proteome in Geographic Atrophy: A Prospective Exploration. Investigative Ophthalmology & Visual Science. 66(15). 24–24.
2.
Cao, J., et al.. (2024). Morphologic Stages of Full-Thickness Macular Hole on Spectral-Domain OCT. Ophthalmology Retina. 9(4). 305–313.
3.
Cao, J., David O. Garcia, José Muñóz, et al.. (2023). Demographic and Socioeconomic Factors in Prospective Retina-Focused Clinical Trial Screening and Enrollment. Journal of Personalized Medicine. 13(6). 880–880. 2 indexed citations
4.
Hu, Qianqian, J. Cao, Bin Fang, et al.. (2023). Differential Chemoproteomics Reveals MARK2/3 as Cell Migration‐Relevant Targets of the ALK Inhibitor Brigatinib. ChemBioChem. 24(11). e202200766–e202200766. 3 indexed citations
5.
Zhang, Lifang, et al.. (2022). Commercial and Instant Coffees Effectively Lower Aβ1-40 and Aβ1-42 in N2a/APPswe Cells. Frontiers in Nutrition. 9. 850523–850523. 2 indexed citations
6.
Yang, Haiqiang, J. Cao, Xiaoyang Lin, et al.. (2022). Developing an Effective Peptide-Based Vaccine for COVID-19: Preliminary Studies in Mice Models. Viruses. 14(3). 449–449. 13 indexed citations
7.
Kim, Janice, et al.. (2021). COVID-19 Vaccines: Current Conditions and Future Prospects. Biology. 10(10). 960–960. 16 indexed citations
8.
Xu, Jinyou, Guoming Liu, Qiyu Huang, et al.. (2018). Kinoform and saw-tooth X-ray refractive lenses development at SSRF. Journal of Instrumentation. 13(7). C07005–C07005. 3 indexed citations
9.
Cao, J., Hang Song, Daniel Dix, et al.. (2007). Inhibition of Corneal Angiogenesis by Topical Administration of VEGF Trap. Investigative Ophthalmology & Visual Science. 48(13). 1710–1710. 1 indexed citations
10.
Cao, J., R.A. Renard, Hang Song, et al.. (2006). Low Dose, Subconjunctival Administration of VEGF Trap Inhibits Suture–Induced Corneal Neovascularization and Inflammation. Investigative Ophthalmology & Visual Science. 47(13). 1626–1626. 2 indexed citations
11.
Cao, J., Hang Song, R.A. Renard, et al.. (2006). Intravitreal Administration of VEGF Trap Suppresses Vascular Leak in the Retinas of Diabetic Rats. Investigative Ophthalmology & Visual Science. 47(13). 1745–1745. 1 indexed citations
12.
Cao, J., et al.. (2005). Systemic Administration of VEGF Trap Suppresses Vascular Leak and Leukostasis in the Retinas of Diabetic Rats. Investigative Ophthalmology & Visual Science. 46(13). 446–446. 3 indexed citations
13.
Wiegand, Stanley J., T. Michael Nork, Paul E. Miller, et al.. (2005). VEGF Trap Both Prevents Experimental Choroidal Neovascularization and Causes Regression of Established Lesions in Non–Human Primates. Investigative Ophthalmology & Visual Science. 46(13). 1411–1411. 4 indexed citations
14.
Wiegand, Stanley J., Hang Song, R.A. Renard, et al.. (2004). Genetic modulation of pigment epithelium–derived factor (PEDF) expression does not alter normal or pathological angiogenesis in the eye, or tumor growth.. Investigative Ophthalmology & Visual Science. 45(13). 1884–1884. 3 indexed citations
15.
Cao, J., R.A. Renard, Hang Song, et al.. (2003). Inhibition of IL-1 Blocks Corneal Inflammation and Neovascularization. Investigative Ophthalmology & Visual Science. 44(13). 823–823. 1 indexed citations
16.
Wiegand, Stanley J., J. Cao, R.A. Renard, J.S. Rudge, & George D. Yancopoulos. (2003). Long-lasting Inhibition of Corneal Neovascularization following Systemic Administration of the VEGF Trap. Investigative Ophthalmology & Visual Science. 44(13). 829–829. 1 indexed citations
17.
Lutty, Gerard A., Makoto Taomoto, J. Cao, et al.. (2001). Inhibition of TNF-alpha-induced sickle RBC retention in retina by a VLA-4 antagonist.. PubMed. 42(6). 1349–55. 27 indexed citations
18.
Cao, J., et al.. (1999). Angiogenic factors in human proliferative sickle cell retinopathy. British Journal of Ophthalmology. 83(7). 838–846. 41 indexed citations
19.
Cao, J.. (1998). Choriocapillaris Degeneration and Related Pathologic Changes in Human Diabetic Eyes. Archives of Ophthalmology. 116(5). 589–589. 289 indexed citations
20.
Worsley, Keith J., et al.. (1996). Statistical analysis of cortical surfaces. NeuroImage. 3(3). S108–S108. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026